2 domains / 4 areas / 2 specializations
Worldwide Clinical Trials
Data updated
Global full-service CRO with a dedicated psychedelic center of excellence and stated experience supporting industry-sponsored psychedelic programs across psychiatric indications.
Clinical Trial Infrastructure Snapshot
CROs & Full-Service Trial DeliveryService Model
Full-Service CRO
Service Coverage
Global
Psychedelic Experience
Verified Psychedelic Trial Experience
Last Source Check
Jun 18, 2026
Public Sources
4
Lifecycle Coverage
Phase Coverage
Capabilities
Research Update
Public-source profile available
Last checked Jun 18, 2026 across 4 sources.
Search Finding
Dedicated psychedelic center of excellence with stated multicountry support since 2017.
Service Notes
Strong CRO-level psychedelic infrastructure record. Country coverage should stay broad until office/site-level evidence is separately reviewed.
Linked Stakeholders
No linked stakeholders yet.
Linked Trials
A Phase 3 Trial to Assess CYB003 in Major Depressive Disorder (EMBRACE)
Recruiting
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) (EXTEND)
Enrolling by invitation
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD) With Depressive Symptoms
Active not recruiting
Phase 1 Bioavailability Study of MELT-100 (Midazolam and Ketamine Sublingual) and IV Midazolam or Ketamine
Completed
Source Evidence
Worldwide — Psychedelics Expertise
https://www.worldwide.com/expertise/neuroscience/psychiatry/psychedelics/
Worldwide + COMPASS Partnership Announcement
https://www.worldwide.com/newsroom/compass-pathways-partners-worldwide-clinical-trials-conduct-worlds-first-large-scale-clinical-trials-psilocybin-therapy-treatment-resistant-depression/
Worldwide Clinical Trials - Contact
https://www.worldwide.com/contact-us/
Worldwide Clinical Trials - Global Reach
https://www.worldwide.com/global-reach/
Consultancy & Advisory Snapshot
Clinical & Operational ConsultingGeography
Global
Coverage
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Pipeline Stage Coverage
Client Types
Consultancy Notes
Worldwide Clinical Trials is a global full-service CRO with a dedicated Psychedelic Center of Excellence within its neuroscience division, supporting sponsor psychedelic programmes since 2017 including one of the first industry-sponsored global psychedelic studies. Documented indications include major depressive disorder, treatment-resistant depression, PTSD, substance use disorders and anorexia nervosa, supported by a CATS clinical assessment training team and a network of psychedelic-ready sites. In July 2024 it partnered with PI-House and the Polish Psychedelic Society to launch the first industry-sponsored psychedelic studies in Poland.
Documented Engagements
First industry-sponsored psychedelic studies in Poland
Jul 23, 2024
Centrum Badan Klinicznych PI-House and Polish Psychedelic Society
Partnership announced at the Nauka Psychodeliczna conference at the University of Warsaw, aiming to establish Poland as a European hub for psychedelic research using PI-House's Gdansk site network.
Worldwide Clinical Trials Partners with PI-House and Polish Psychedelic SocietySource Evidence
Worldwide Clinical Trials official website
https://www.worldwide.com
Worldwide Clinical Trials psychedelics expertise
https://www.worldwide.com/expertise/neuroscience/psychiatry/psychedelics/
Worldwide partners with PI-House and Polish Psychedelic Society
https://www.worldwide.com/newsroom/worldwide-clinical-trials-partners-with-pi-house-and-polish-psychedelic-society/
Quick Facts
- Type
- cro
- HQ
- Research Triangle Park headquarters - 600 Park Offices Drive Suite 200, Durham, NC 27713, United States
- Website
- Visit
Research Landscape
What the 4 registered trials Worldwide Clinical Trials sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
What's live right now, and what stopped?
SourcedRegistry status of all 4 Worldwide Clinical Trials trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.